Gilead Sciences Inc. (GILD)

• Annual Data
• Quarterly Data

Gilead Sciences Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity

		Dec 31, 2018		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014
	Accounts payable
	Accrued government and other rebates
	Compensation and employee benefits
	Accrued payment for marketing-related rights acquired from Japan Tobacco
	Income taxes payable
	Other accrued expenses
	Other accrued liabilities
	Current portion of long-term debt and other obligations, net
	Current liabilities
	Long-term debt, net, excluding current portion
	Long-term income taxes payable
	Other long-term obligations
	Long-term liabilities
	Total liabilities
	Equity component of currently redeemable convertible notes
	Preferred stock, par value $0.001 per share; none outstanding
	Common stock, par value $0.001 per share
	Additional paid-in capital
	Accumulated other comprehensive income
	Retained earnings
	Total Gilead stockholders’ equity
	Noncontrolling interest
	Total stockholders’ equity
	Total liabilities and stockholders’ equity

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).